Bortezomib in the management of multiple myeloma

Multiple myeloma (MM) is a B-cell malignancy characterized by clonal expansion of plasma cells within the bone marrow, the presence of a serum and/or urine monoclonal protein, lytic bone lesions, and anemia. On a cellular level, the disease is characterized by complex interactions between tumor cell...

Descripción completa

Detalles Bibliográficos
Autores principales: Laubach, Jacob P, Mitsiades, Constantine S, Hideshima, Teru, Schlossman, Robert, Chauhan, Dharminder, Munshi, Nikhil, Ghobrial, Irene, Carreau, Nicole, Anderson, Kenneth C, Richardson, Paul G
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2009
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3004671/
https://www.ncbi.nlm.nih.gov/pubmed/21188129

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3004671/
https://www.ncbi.nlm.nih.gov/pubmed/21188129

Ejemplares similares